✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Ind-Swift Laboratories Ltd.

INDSWFTLAB

Market Cap
₹522 Cr.
P/E
2.17

Ind-Swift Laboratories Ltd.

  • Ind-Swift Lab.
  • Albert David
  • Jenburkt Pharma
FAQs on Ind-Swift Laboratories Ltd. Shareprice

Ind-Swift Lab. has given better returns compared to its competitors.
Ind-Swift Lab. has grown at ~14.7% over the last 6yrs while peers have grown at a median rate of 14.15%

Ind-Swift Lab. is not expensive.
Latest PE of Ind-Swift Lab. is 2.14, while 3 year average PE is 10.1.
Also latest EV/EBITDA of Ind-Swift Lab. is 0.0 while 3yr average is 5.76.

View FAQ's On Business
Growth Table
  • Ind-Swift Laboratories Ltd.
  • Albert David
  • Jenburkt Pharma
Balance Sheet
  • Ind-Swift Laboratories Ltd.
  • Albert David
  • Jenburkt Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Ind-Swift Laboratories Ltd.
  • Albert David
  • Jenburkt Pharma
Cash Flow
  • Ind-Swift Laboratories Ltd.
  • Albert David
  • Jenburkt Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Ind-Swift Laboratories Ltd.
  • Albert David
  • Jenburkt Pharma
Quarterly Results
  • Ind-Swift Laboratories Ltd.
  • Albert David
  • Jenburkt Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Ind-Swift Laboratories Ltd. Financials

Balance sheet of Ind-Swift Lab. is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Ind-Swift Lab. is increasing.
Latest debt of Ind-Swift Lab. is -₹422.06 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹848.51 Crs.

The profit is oscillating.
The profit of Ind-Swift Lab. is ₹240 Crs for TTM, ₹421 Crs for Mar 2024 and ₹47.6 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Ind-Swift Lab. latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech